Print

Testing a Vaccine for Treating or Preventing Triple-Negative Breast Cancer

https://www.facingourrisk.org/research-clinical-trials/study/285/treatment-study-for-people-with-stage-2-or-3-triple-negative-breast-cancer-at-high-risk-for-recurrence

Clinicaltrials.gov identifier:
NCT04674306 (https://clinicaltrials.gov/show/NCT04674306)


Treatment study for people with stage 2 or 3 triple-negative breast cancer at high risk for recurrence


About the Study

NOTE: This study is no longer recruiting people. 

Researchers are studying the affects of this breast cancer vaccine on the immune system in the following groups:

 


This Study is Open To:

NOTE: This study is no longer recruiting people. 

This Study is Not Open To:

NOTE: This study is no longer recruiting people. 


About FORCE

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.